Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Morphosys AG O.N. (MORG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
67.70 +0.25    +0.37%
08:33:41 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE0006632003 
S/N:  663200
  • Volume: 321
  • Bid/Ask: 67.65 / 67.85
  • Day's Range: 67.55 - 67.70
Morphosys AG 67.70 +0.25 +0.37%

MORG Recent Sentiments

 
This page contains information on users’ sentiments for the Morphosys AG O.N. stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Mar 12, 2024 Silvia Roloff   65.97 Apr 05, 2024 @ 67.05 +1.64%
Feb 26, 2024 Joe Bond   65.28 Mar 04, 2024 @ 65.22 -0.09%
Feb 16, 2024 Silvia Roloff   65.61 Mar 08, 2024 @ 65.30 -0.47%
Feb 07, 2024 Yasmina Raupova   63.56 Mar 01, 2024 @ 65.50 +3.05%
Feb 06, 2024 Daniele Bellotti   65.41 Mar 01, 2024 @ 65.50 -0.14%
Feb 06, 2024 Franz Mattmann   65.38 Feb 08, 2024 @ 63.69 -2.58%
Feb 06, 2024 Ilusior Infinita   56.96 Feb 12, 2024 @ 64.50 +13.24%
Feb 06, 2024 Hasan Kislali   65.98 Mar 01, 2024 @ 65.50 +0.73%
Feb 05, 2024 Rolf Allerding   41.40 Mar 01, 2024 @ 65.50 +58.19%
Feb 01, 2024 alvaro bitali   40.10 Feb 23, 2024 @ 65.52 +63.41%
Jan 30, 2024 Alex Cash   40.28 Feb 23, 2024 @ 65.52 -62.64%
Jan 29, 2024 Antonio Martins   39.42 Feb 05, 2024 @ 56.96 +44.50%
Jan 19, 2024 Dénes Roskó   32.94 Feb 09, 2024 @ 64.14 -94.72%
Jan 19, 2024 Florian Dichtl   32.16 Feb 09, 2024 @ 64.14 +99.44%
Jan 19, 2024 Florian Dichtl   32.20 Jan 19, 2024 @ 32.16 -0.12%
Jan 19, 2024 Willy Meyer   37.12 Feb 09, 2024 @ 64.14 +72.79%
Jan 18, 2024 Rexhepi Nexhmedin   36.88 Feb 09, 2024 @ 64.14 +73.94%
Jan 17, 2024 Uri Jota   40.66 Feb 09, 2024 @ 64.14 +57.75%
Jan 16, 2024   36.71 Jan 16, 2024 @ 37.51 -2.21%
Jan 16, 2024 jordi font   36.26 Jan 22, 2024 @ 33.42 -7.82%
Jan 15, 2024 Johannes Ehrich   33.71 Jan 22, 2024 @ 33.42 -0.86%
Jan 12, 2024 Timo Müller   30.64 Feb 02, 2024 @ 42.35 +38.26%
Jan 08, 2024 xxx never xxx   36.22 Feb 02, 2024 @ 42.35 +16.92%
Jan 04, 2024 Sonja MüRo   33.34 Jan 18, 2024 @ 41.24 +23.71%
Dec 21, 2023 Zainetto Fiscale   31.21 Dec 22, 2023 @ 30.79 +1.35%
Dec 21, 2023 Zainetto Fiscale   31.70 Dec 21, 2023 @ 31.44 +0.82%
Dec 19, 2023 Dénes Roskó   33.20 Jan 12, 2024 @ 30.43 -8.33%
Dec 11, 2023 Timo Müller   33.34 Jan 05, 2024 @ 35.35 +6.04%
Dec 11, 2023 Antonio Martins   28.52 Dec 18, 2023 @ 35.00 +22.70%
Dec 11, 2023 The Flash   28.17 Jan 05, 2024 @ 35.35 +25.53%
Dec 11, 2023 Jan Dölle   28.11 Dec 18, 2023 @ 35.00 +24.49%
Dec 07, 2023 Andreas Klett   24.92 Dec 11, 2023 @ 33.18 +33.17%
Dec 06, 2023 Malamati Spiridonidou   26.57 Dec 29, 2023 @ 33.99 +27.97%
Dec 05, 2023 JayHid   27.07 Dec 19, 2023 @ 32.89 +21.52%
Dec 04, 2023 Ha Schmidt   24.98 Dec 11, 2023 @ 33.18 +32.83%
Nov 30, 2023 Silvia Roloff   23.59 Dec 22, 2023 @ 32.48 +37.66%
Nov 24, 2023 Cedrick Peters   16.46 Dec 15, 2023 @ 33.10 +101.00%
Nov 23, 2023 NIKOLAOS SOLDATOS   16.25 Nov 30, 2023 @ 20.00 +23.04%
Nov 23, 2023 carmine buonomo   16.36 Dec 15, 2023 @ 33.10 +102.32%
Nov 21, 2023 Alexander Schröder   16.80 Nov 30, 2023 @ 20.00 +19.08%
Nov 21, 2023 Hongwen Ma   15.96 Nov 30, 2023 @ 23.70 +48.42%
Nov 21, 2023 Matvei Egorov   16.08 Dec 15, 2023 @ 33.10 +105.81%
Nov 21, 2023 Michael Lange   15.54 Nov 21, 2023 @ 15.57 +0.23%
Nov 21, 2023 Fl Si   15.54 Dec 15, 2023 @ 33.10 -113.04%
Nov 20, 2023 Joe López Lopez   21.94 Dec 15, 2023 @ 33.10 +50.84%
Nov 15, 2023 Thomas Krammer   27.80 Dec 08, 2023 @ 24.30 -12.57%
Nov 03, 2023 Ha Schmidt   29.94 Nov 30, 2023 @ 20.00 -33.20%
Oct 09, 2023 Manuel Santos Ramos   22.71 Nov 30, 2023 @ 20.00 -11.95%
Sep 28, 2023 Timo Müller   27.36 Nov 30, 2023 @ 20.00 -26.89%
Sep 20, 2023 xxx never xxx   29.54 Nov 30, 2023 @ 20.00 -32.30%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MORG Comments

Write your thoughts about Morphosys AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
gowtham kotha
gowtham kotha Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I would like to buy this. Any suggestions.
Robert Kable
Robert Kable Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Negative clinical trials results… not sure if 31% doen warranted, but good to investigate first.
gowtham kotha
gowtham kotha Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thankyou for the details. Also results shall be out tomorrow.
gowtham kotha
gowtham kotha Nov 14, 2022 5:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let me wait and see
gowtham kotha
gowtham kotha Jun 29, 2022 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why its going down
Robert Laszlo
Robert Laszlo Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
from now it will move up above 50 ...
Fa We
Fa___We Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Obviously you were wrong.
Robert Laszlo
Robert Laszlo Aug 18, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in Aug moved up over 50 and i sold all shares at 49.88... now i dont care
Bm Bendary
Bm Bendary Aug 02, 2021 7:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wounder why the stock has been hit so hard? Its almost @50% ot march last year when the entire market crashed!! I dont beleive lowering the upper limit of the FY revenue guidance is the driver. I have to say that ive not spent quality time understanding the fundamental of this company, i only strated to follow it recently. Appreciate your insights. Thanks
Doe John
Doe John Jul 26, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any idea?
Jon Lovbacka
Jon Lovbacka Jul 26, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Announced a narrowing of revenue guidance. There are better options out there, but today might be a good entry point as the negative reaction (incl. yesterday) seems excessive.
george bush
george bush Apr 21, 2021 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://ch.marketscreener.com/kurs/aktie/MORPHOSYS-AG-436425/news/COMPANY-TALK-J-J-nbsp-41-Prozent-Plus-mit-Morphosys-Wirkstoff-33013409/
george bush
george bush Apr 12, 2021 8:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong buy
george bush
george bush Mar 25, 2021 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
European approval for tafasitamab is due at the end of May
Bert Muermans
Bert Muermans Mar 15, 2021 5:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Damn good results published!!!
Bert Muermans
Bert Muermans Mar 15, 2021 1:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When (what time)  is the news public concerning their yearresults?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email